Literature DB >> 15493013

Glioblastoma cells deficient in DNA-dependent protein kinase are resistant to cell death.

George G Chen1, Fanny L F Sin, Billy C S Leung, Ho K Ng, Wai S Poon.   

Abstract

DNA-dependent protein kinase (DNA-PK), a nuclear serine/threonine kinase, is responsible for the DNA double-strand break repair. Cells lacking or with dysfunctional DNA-PK are often associated with mis-repair, chromosome aberrations, and complex exchanges, all of which are known to contribute to the development of human cancers including glioblastoma. Two human glioblastoma cell lines were used in the experiment, M059J cells lacking the catalytic subunit of DNA-PK, and their isogenic but DNA-PK proficient counterpart, M059K. We found that M059K cells were much more sensitive to staurosporine (STS) treatment than M059J cells, as demonstrated by MTT assay, TUNEL detection, and annexin-V and propidium iodide (PI) staining. A possible mechanism responsible for the different sensitivity in these two cell lines was explored by the examination of Bcl-2, Bax, Bak, and Fas. The cell death stimulus increased anti-apoptotic Bcl-2 and decreased pro-apoptotic Bcl-2 members (Bak and Bax) and Fas in glioblastoma cells deficient in DNA-PK. Activation of DNA-PK is known to promote cell death of human tumor cells via modulation of p53, which can down-regulate the anti-apoptotic Bcl-2 member proteins, induce pro-apoptotic Bcl-2 family members and promote a Bax-Bak interaction. Our experiment also demonstrated that the mode of glioblastoma cell death induced by STS consisted of both apoptosis and necrosis and the percentage of cell death in both modes was similar in glioblastoma cell lines either lacking DNA-PK or containing intact DNA-PK. Taken together, our findings suggest that DNA-PK has a positive role in the regulation of apoptosis in human glioblastomas. The aberrant expression of Bcl-2 family members and Fas was, at least in part, responsible for decreased sensitivity of DNA-PK deficient glioblastoma cells to cell death stimuli. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15493013     DOI: 10.1002/jcp.20230

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  The DNA-PK catalytic subunit regulates Bax-mediated excitotoxic cell death by Ku70 phosphorylation.

Authors:  Jia Liu; Janice R Naegele; Stanley L Lin
Journal:  Brain Res       Date:  2009-08-04       Impact factor: 3.252

2.  Functional interplay between caspase cleavage and phosphorylation sculpts the apoptotic proteome.

Authors:  Melissa M Dix; Gabriel M Simon; Chu Wang; Eric Okerberg; Matthew P Patricelli; Benjamin F Cravatt
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

Review 3.  Chapter seven--Cancer treatment with gene therapy and radiation therapy.

Authors:  Sergey A Kaliberov; Donald J Buchsbaum
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

4.  Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis.

Authors:  F Wang; K Bhat; M Doucette; S Zhou; Y Gu; B Law; X Liu; E T Wong; J X Kang; T-C Hsieh; S Y Qian; E Wu
Journal:  Curr Mol Med       Date:  2011-08       Impact factor: 2.222

5.  Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells.

Authors:  Resham Lal Gurung; Shi Ni Lim; Aik Kia Khaw; Jasmine Fen Fen Soon; Kirthan Shenoy; Safiyya Mohamed Ali; Manikandan Jayapal; Swaminathan Sethu; Rajamanickam Baskar; M Prakash Hande
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

6.  Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization.

Authors:  Ahmet Cingöz; Ezgi Ozyerli-Goknar; Tunc Morova; Fidan Seker-Polat; Myvizhi Esai Selvan; Zeynep Hülya Gümüş; Deepak Bhere; Khalid Shah; Ihsan Solaroglu; Tugba Bagci-Onder
Journal:  Oncogene       Date:  2021-03-25       Impact factor: 9.867

7.  Enhanced genotoxicity of silver nanoparticles in DNA repair deficient Mammalian cells.

Authors:  Hui Kheng Lim; P V Asharani; M Prakash Hande
Journal:  Front Genet       Date:  2012-06-13       Impact factor: 4.599

Review 8.  Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.

Authors:  Fabliha Ahmed Chowdhury; Md Kamal Hossain; A G M Mostofa; Maruf Mohammad Akbor; Muhammad Shahdaat Bin Sayeed
Journal:  Biomed Res Int       Date:  2018-01-31       Impact factor: 3.411

9.  Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs.

Authors:  Vladimir L Sukhorukov; Michael Flentje; Cholpon S Djuzenova; Thomas Fischer; Astrid Katzer; Dmitri Sisario; Tessa Korsa; Gudrun Steussloff
Journal:  BMC Cancer       Date:  2021-11-11       Impact factor: 4.430

10.  Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis.

Authors:  David Y L Chan; George G Chen; Wai S Poon; Pi C Liu
Journal:  J Neurooncol       Date:  2007-10-11       Impact factor: 4.130

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.